UCLA researchers helped test the first drug approved by the Food and Drug Administration to treat liver cancer in 10 years. They found through clinical trials that the drug, regorafenib, increased overall liver cancer patient survival period from a median of 7.8 months to 10.6 months. Read more...

Photo: The Food and Drug Administration approved the expansion of the use of regorafenib to treat advanced liver cancer April 27 with the help of a UCLA-led research. (Daily Bruin file photo)

UCLA researchers are using sweat to diagnose and track diseases such as cystic fibrosis and diabetes. The researchers developed a wearable wristband that continuously gathers health-related data from sweat, said Sam Emaminejad, assistant professor of electrical engineering at UCLA and lead author of the researchers’ study published in 2016. Read more...

Photo: Sam Emaminejad, one of the project leaders for the development of sweat-based diagnostic technology, shows a graduate student a technique for developing the wristband. (Katherine Zhuo/Daily Bruin)

Midway through his newly published book, Neil Garg poses a serious scientific question to his reader. “What’s a chemical in coffee that adults like so much?” The question is scrawled in chunky cartoon letters inside the children’s coloring book he created. Read more...

Photo: Neil Garg, a professor of chemistry and biochemistry, released a self-published coloring book about organic chemistry April 22. He said he was inspired by his daughters’ curiosity in science. (Courtesy of Neil Garg)